Apotex, Inc.: Company Profile and SWOT Analysis by ICDResearch

VIEWS: 49 PAGES: 19

More Info
									Apotex, Inc.

_________________________________________________________________________________



Apotex, Inc.                                                          Key Employees
                                                                      Name                         Job Title
Fast Facts
                                                                                                   Chairman, Chief Executive
                                150 Signet Drive, Toronto, M9L 1T9,   Bernard C. Sherman
Headquarters Address                                                                               Officer
                                Canada
                                                                                                   Chief Operating Officer,
                                                                      Jacob M. Jack Kay
Telephone                       + 1 800 2684623                                                    President
                                                                      Jeff Watson                  Chief Commercial Officer
Fax                             + 1 800 6099444

                                                                      Steven Giuli                 Director Public Affairs
Website                         www.apotex.com

Ticker Symbol, Stock Exchange   N/A
                                                                      Company Overview
Number of Employees             5,800
                                                                      Apotex Inc. (Apotex) is one of the leading
Fiscal Year End                 N/A
                                                                      generic drugmakers in Canada. The company
                                                                      engages in the research, development,
Revenue (in US$ million)        970.87
                                                                      manufacture and distribution of generic drugs in
Revenue (in CAD million)        1,000.00
                                                                      Canada and internationally. The company
                                                                      produces around 300 generic drugs in more
                                                                      than 4,000 dosages and formats. It also
                                                                      develops, manufactures and distributes fine
                                                                      chemicals, non-prescription and private label
                                                                      medicines, disposable plastics, packaging
SWOT Analysis                                                         components, and medical devices for medical
                                                                      use. Through agreement and subsidiaries,
Strengths                       Weaknesses                            Apotex exports to more than 115 countries
                                                                      across Turkey, Belgium, Australia, Czech
                                                                      Republic, Netherlands, Mexico, Poland, New
Deals and Alliances             Patent litigation
                                                                      Zealand, and the UK. The company is
                                                                      headquartered in Toronto, Canada.
Fully integrated system         Product recalls

Resolute research activities                                          Key Competitors
                                                                      Jamieson Laboratories Ltd.
Wide geographical presence
                                                                      Ranbaxy Laboratories Limited (Ticker: 500359)
Opportunities                   Threats
                                                                      Sandoz International GmbH
Changing demographics           Foreign exchange risks                Teva Pharmaceutical     Industries       Limited   (Ticker:
                                                                      TEVA)
                                Tightening of the FDA’s regulatory
Recovering economy
                                oversight                             Watson Pharmaceuticals, Inc. (Ticker: WPI)




___________________________________________________________________________________________

Apotex, Inc. - SWOT Profile                                                                                      Page 1
Apotex, Inc.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 4
    1.1     Company Overview .................................................................................................................................................4
    1.2     Business Description ...............................................................................................................................................4
    1.3     Major Products and Services ...................................................................................................................................5
2     Mergers & Acquisitions and Partnerships ............................................................................................. 6
    2.1     M&A and Partnerships Strategy ..............................................................................................................................6
3     Recent Developments ............................................................................................................................. 8
4     SWOT Analysis ...................................................................................................................................... 10
    4.1     SWOT Analysis - Overview ...................................................................................................................................10
    4.2     Strengths ...............................................................................................................................................................10
    4.3     Weaknesses ..........................................................................................................................................................11
    4.4     Opportunities .........................................................................................................................................................11
    4.5     Threats ...................................................................................................................................................................12
5     Apotex, Inc. - Company Statement ....................................................................................................... 13
6     Apotex, Inc. - History ............................................................................................................................. 14
7     Apotex, Inc. - Key Employees ............................................................................................................... 16
8     Apotex, Inc. - Key Employee Biographies ........................................................................................... 17
9     Apotex, Inc. - Locations and Subsidiaries ........................................................................................... 18
    9.1     Head Office ............................................................................................................................................................18
    9.2     Other Locations and Subsidiaries ..........................................................................................................................18
10    Appendix ................................................................................................................................................ 19
    10.1    Methodology ..........
								
To top